Pulse Biosciences, Inc. (PLSE) Shareholders’ equity 2020–2025
Pulse Biosciences, Inc. (PLSE) shareholders’ equity at each fiscal year-end, per SEC filings.
$80.7MFY2025 · since FY2020: $22.9M → $80.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $80.7M | -29.8% |
| FY2024 | $114.9M | +158.9% |
| FY2023 | $44.4M | +2073.3% |
| FY2022 | -$2.2M | -105.1% |
| FY2021 | $44.4M | +93.8% |
| FY2020 | $22.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice